Stability indicating RP- HPLC method for Cyclosporine Eye drops (#295)
Cyclosporine A (CsA) is a lipophilic cyclic polypeptide composed of 11 amino acids, seven of which are N-methylated . It has been utilized clinically as a potent
immunosuppressant to prevent allograft rejection in various organ
transplantations and to treat systemic and local autoimmune disorders
[1, 2]. Study by E.Demiryay et al concluded that Opthalmic admistration
of Cyclsoporine in artificial tears significantly increases goblet cell
density, decreases the signs of DTS (dysfunctional tear syndrome) and
improves ocular surface health [3]. Although Cyclosporine ophthalmic
emulsion has been on the market for a few years now, exact guidelines on
how often and how long dry-eye patients should use it are still
debatable. So therefore a high-performance liquid chromatography (HPLC)
method was developed and validated to be stability-indicating by stress
degradation tests.Due to the cyclic structure and inherent
intra-molecular hydrogen bonds, cyclosporine is very stable under normal
conditions. However, degradation occurs under stress conditions.
Separation of multiple components by HPLC analysis of stability samples
possess high accuracy and sensitivity for even small quantities of
degradation products produced. In this work, an Acetonitrile-based HPLC
method with short run time, with better peak shape and resolution from
the excipients has been developed and validated according to the
guidance regulated in FDA, and USP. The separation was on a Waters
Spherisorb� S5 ODS2 4.6 x 250mm 1.d. reversed phase column at 80� using
80:20 Acetonitrile: water as Mobile phase. Detection was by UV at 210nm,
maintained a flow rate of 1mL /min with 20�l injection volume.Three
stress conditions were applied: Acid, Alkali, and heat for degradation
study. It has been found potential degradation products Isocyclosporine,
and Dihydroxy cyclosporine were produced as a result of forced
degradation with well resolved and separated peaks from the active
indicating successful degradation and stability indicating
- C. J. Dunn, A. J. Wagstaff, C. M. Perry, G. L. Posker, K. L. Goa, Drugs 61, 1957(2001)
- G. S. Zijlstra, M. Rijkeboer, D. Jan van Drooge, M. Sutter, W. Jiskoot, M. van de Weert,W. L. Hinrichs, H. W. Frijlink, AAPS J. 9, E190 (2007)
- E.Demiryay, V.Yayali, E.N. Cetin, C.Yidirum, Eye Contact lens,31-35 Sep 37 (5) (2011)